JRCT ID: jRCT1080225354
Registered date:26/08/2020
Effect of biotin on blood data
Basic Information
| Recruitment status | completed |
|---|---|
| Health condition(s) or Problem(s) studied | - |
| Date of first enrollment | 07/12/2020 |
| Target sample size | 30 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | investigational material(s) Generic name etc : Lumipulse INN of investigational material : - Therapeutic category code : Dosage and Administration for Investigational material : - control material(s) Generic name etc : Elecsys INN of investigational material : Therapeutic category code : Dosage and Administration for Investigational material : - |
Outcome(s)
| Primary Outcome | confirmatory Fertility assays(LH,FSH,AMH,E2,Progesterone,Prolactin,Teststerone) |
|---|---|
| Secondary Outcome | - |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | - getting informed consent - apparently healthy - who can take biotin supplements - who can take bloods 7-10mL and 4 times a day - who do not take the supplements and hormone treatment 1 week before the examination |
| Exclude criteria | - pregnancy - surgery within 6 months - BMI is less than 18 or more than 30 - under hormone treatment - under IVF treatment |
Related Information
| Primary Sponsor | Yoshimasa Asada |
|---|---|
| Secondary Sponsor | Tomoaki Sato |
| Source(s) of Monetary Support | Fujirebio Inc. |
| Secondary ID(s) | JapicCTI-205450 |